You have 9 free searches left this month | for more free features.

Condition

Melanoma (1)

Prostatic Neoplasms (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Centocor, Inc. (2)

Collaborator

Janssen-Cilag Farmaceutica, S.R.L. (1)

Intervention

intetumumab (2)

placebo (2)

dacarbazine (1)

docetaxel (1)

prednisone (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

intetumumab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma Trial in Germany, United Kingdom, United States (Intetumumab, Dacarbazine, Placebo)

Completed

Melanoma

Intetumumab
+2 more

Scottsdale, Arizona
+31 more

Jul 17, 2013

Prostatic Tumors Trial in Worldwide (Docetaxel, Prednisone, Intetumumab)

Completed

Prostatic Neoplasms

Docetaxel
+3 more

Birmingham, Alabama
+59 more

Jun 12, 2013